/ /

  • linkedin
  • Increase Font
  • Sharebar

    6 things you need to know: Genetic markers for glaucoma identified


    Disquafosol improves dryness symptoms for contact lens wearers

    A study evaluating the efficacy of topical application of 3% diquafosol tetrasodium solution for the treatment of soft contact lens wearers with dryness found the solution improved biomarker of membrane-associated mucins, tear film break-up time (TBUT), staining of cornea and conjunctiva, and subjective symptoms.

    In addition to clinical tests and subjective symptoms, researchers assessed the fluorescence intensity of wheat germ agglutinin conjugate of fluorescein (F-WGA) used as a marker of membrane-associated mucins and sialic acid concentration in tear fluids as a marker of secreted mucins.

    Recent: Why patients are choosing eyecare apps over you

    Researchers treated for four weeks 12 soft contact lens wearers with dryness symptoms with diquafosol. Clinical tests included TBUT, corneal and conjunctival fluorescein staining scores, and Schirmer values. Researchers evaluated subjective symptoms using the Dry Eye-Related Quality-of-Life Score (DEQS).

    Fluorescence intensities in the central cornea were measured by fluorophotometry at five minutes after a 5% F-WGA solution was applied to the eye. The tears collected by the Schirmer test strips were analyzed by high-performance liquid chromatography, and the concentrations of sialic acid, total protein, and the four major tear proteins secretory IgA, lactoferrin, lipocalin-1, and lysozyme proteins were measured.

    The study found that comparing the results before and after diquafosol treatment, TBUT, kerato-conjunctival staining score, corneal staining score, and DEQS score showed statistically significant improvements. The study also found that F-WGA fluorescence intensities significantly increased after treatment, whereas the concentrations of sialic acid and tear proteins remained unchanged.

    Next: Allergan announces positive pivotal trial results for Oculeve Intranasal Tear Neurostimulator

    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V